The National Pharmaceutical Pricing Authority (NPPA), a regulatory agency under the Union Ministry of Chemicals and Fertilizers, has fixed the retail prices of 84 basic drug formulations utilised in treating different diseases.
In a notification by the NPPA to the pharmaceutical companies, they strictly advised them to follow the prices. Further warned that failing to do so would come with significant liabilities and payment of the overcharged amount with interest.
Type 2 diabetes, high blood pressure and gastrointestinal disorder are drug formulations with fixed prices. Along with the medicines taken to reduce triglyceride levels in the blood to prevent heart attack and stroke.
The Atorvastatin and Fenofibrate tablets were priced at Rs 13.87, a tablet sold by Cipla and Pure & Care Healthcare. Patients with diabetes and heart conditions consume the medication.
Olmesartan plus Medoxomil plus Amlodipine plus Hydrochlorothiazide used to treat heart and blood pressure disorders has a retail price of Rs 12.91 per tablet. German Remedies Pharmaceuticals and Akums Drugs & Pharmaceuticals Ltd. both sell the medication.
According to the regulation, a single tablet of Voglibose and (SR) Metformin Hydrochloride will cost Rs 10.47, excluding GST. At the same time, the cost of paracetamol and caffeine per tablet was fixed at Rs 2.88.
Additionally, a single capsule of rosuvastatin, aspirin, and clopidogrel fixated at Rs 13.91.
The NPPA ordered the medicine manufacturers to submit a price list using the Integrated Pharmaceutical Database Management System (IPDMS). It allegedly also said that the state drug regulators should receive a copy.
The order says, “As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner to be easily accessible to any person wishing to consult the same,”
The revised ceiling price of liquid medical oxygen and oxygen inhalation (medicinal gas) this year extended till 30 September, said NPPA in a separate notification.